ACC-018

N/A

Report date: 2022/12/07 17:52:59
NME

Base Information

Drug NameACC-018
Drug Alias NameACC-018
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionReverse transcriptase inhibitorsHBV DNA Polymerase inhibitors
TargetsReverse transcriptaseDNAHBV DNA Polymerase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A